Cargando…

Suppression of high lipid diet induced by atherosclerosis sarpogrelate

Sarpogrelate (SP), a serotonin (5-HT2A) receptor antagonist, is used as an anti-platelet agent for the treatment of some vascular diseases. SP has been reported to inhibit 5-HT induced coronary artery spasm, increase in intracellular calcium and smooth muscle cells proliferation. This study was unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yan-Jun, Zhang, Ming, Ji, Lei, Elimban, Vijayan, Chen, Li, Dhalla, Naranjan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823433/ https://www.ncbi.nlm.nih.gov/pubmed/22348587 http://dx.doi.org/10.1111/j.1582-4934.2012.01554.x

Ejemplares similares

Reduction of blood pressure by store‐operated calcium channel blockers
por: Xu, Yan‐Jun, et al.
Publicado: (2015)

Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease
por: Dhalla, Naranjan S., et al.
Publicado: (2022)

β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)

Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction
por: Babick, Andrea, et al.
Publicado: (2012)

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
por: Shah, Anureet K., et al.
Publicado: (2021)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice
por: Kim, Dong-hyun, et al.
Publicado: (2016)

Aspirination of α-Aminoalcohol (Sarpogrelate M1)
por: Park, Sunhwa, et al.
Publicado: (2016)

Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
por: Tappia, Paramjit S., et al.
Publicado: (2022)

Mechanisms of the lysophosphatidic acid-induced increase in [Ca(2+)](i) in skeletal muscle cells
por: Xu, Yan-Jun, et al.
Publicado: (2008)

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
por: Bhullar, Sukhwinder K., et al.
Publicado: (2022)

The Role of ERK1/2 Activation in Sarpogrelate-Mediated Neuroprotection
por: Ku, Cristy A., et al.
Publicado: (2018)

Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High-Cholesterol Diet-Induced Chronic Kidney Disease in ApoE-Deficient Mice
por: Xu, Jingyi, et al.
Publicado: (2020)

The Prevention of Contrast Induced Nephropathy by Sarpogrelate: a Prospective Randomized Controlled Clinical Trial
por: Ki, You-Jeong, et al.
Publicado: (2019)

Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice
por: Liu, Hongyang, et al.
Publicado: (2020)

Novel usage of sarpogrelate hydrochloride in patients with allergy-related variant angina
por: Noma, Kensuke, et al.
Publicado: (2012)

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
por: Fouad Shalaby, Mohammed, et al.
Publicado: (2021)

Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
por: Müller, By Alison L, et al.
Publicado: (2010)

Protein Kinases as Drug Development Targets for Heart Disease Therapy
por: Dhalla, Naranjan S., et al.
Publicado: (2010)

Effectiveness of Some Vitamins in the Prevention of Cardiovascular Disease: A Narrative Review
por: Shah, Anureet K., et al.
Publicado: (2021)

Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure
por: Bhullar, Sukhwinder K., et al.
Publicado: (2023)

Modification of Ischemia/Reperfusion-Induced Alterations in Subcellular Organelles by Ischemic Preconditioning
por: Tappia, Paramjit S., et al.
Publicado: (2022)

Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2013)

Reciprocal regulation of transcription factors and PLC isozyme gene expression in adult cardiomyocytes
por: Singal, Tushi, et al.
Publicado: (2010)

Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias
por: Adameova, Adriana, et al.
Publicado: (2020)

Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy
por: Dhalla, Naranjan S., et al.
Publicado: (2020)

Effects of sarpogrelate, a 5-hydroxytriptamine 2A receptor antagonist on endotoxin shock in rats
por: Nishiyama, T
Publicado: (2005)

Application of physiologically based pharmacokinetic modeling in predicting drug–drug interactions for sarpogrelate hydrochloride in humans
por: Min, Jee Sun, et al.
Publicado: (2016)

Effects of sarpogrelate hydrochloride on peripheral arterial disease: A meta-analysis of randomized controlled trials
por: Lu, Yunxin, et al.
Publicado: (2019)

Editorial: Nutritional Intervention in Cardiovascular Diseases: From Basic Science to Applied Investigations
por: Jakovljevic, Vladimir Lj., et al.
Publicado: (2022)

Therapeutic activity of sarpogrelate and dopamine D(2) receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes
por: Fouad Shalaby, Mohammed Ahmed, et al.
Publicado: (2021)

TNF-α-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy
por: Das, Samarjit, et al.
Publicado: (2010)

SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial
por: Ahn, Sanghyun, et al.
Publicado: (2017)

Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury
por: Dhalla, Naranjan S., et al.
Publicado: (2022)

Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results
por: Chen, Yue-Xin, et al.
Publicado: (2015)

Effect of sarpogrelate and high‐dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study
por: Kim, So Ree, et al.
Publicado: (2019)

Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice
por: Lee, Eun Soo, et al.
Publicado: (2017)

The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial
por: Park, Kyungil, et al.
Publicado: (2010)

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)
por: Nomura, Shosaku, et al.
Publicado: (2018)

Sarpogrelate Based Triple Antiplatelet Therapy Improved Left Ventricular Systolic Function in Acute Myocardial Infarction: Retrospective Study
por: Choi, Jae Hyuk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c29mnahbqjoojd5mtp09t92hgj